Since 2013 Dr. Schols has been Head of the Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KULeuven; Head of the subdivision Rega General and head of the Subdivision Chemotherapy. Chairman of the Rega Foundation. Dr. Schols is also a member of the board of directors of the Rega Institute; member of the board and the council of the Department Microbiology, Immunology and Transplantation. His main research interests: Chemotherapy of retroviral diseases with special emphasis on HIV/AIDS; Cellular (chemokine) receptors as targets for specific and broad-spectrum anti-viral therapy for HIV, herpes virus, dengue virus and zika virus; Molecular mechanisms of antiviral drug resistance and viral escape mechanisms; Potential role of modified chemokines/ chemokine receptor inhibitors in diseases such HIV, cancer, inflammation and imaging applications; Development of microbicidal agents to inhibit sexual transmission of HIV and herpes virus. Prof. Dominique Schols is author or co-author of ~480 publications in peer-reviewed journals and according to the ISI Web of Science > 10,100 times cited with an h-index of 73.